Epstein-Barr virus
FDA Fails to Approve Ebvallo
The FDA issued a CRL to Atara Biotherapeutics for tabelecleucel to treat Epstein-Barr virus positive ...
JANUARY 17, 2025
Experimental Monoclonal Antibodies Show Promise Against Epstein-Barr Virus
Multiple sites of the Epstein-Barr virus appear to be vulnerable. A panel of investigational monoclonal antibodies ...
NOVEMBER 9, 2022
Epstein-Barr Virus May Be Leading Cause of MS
Establishing a causal relationship between the virus and disease has been difficult because EBV infects ...
JANUARY 18, 2022
Schizophrenia Linked With Abnormal Immune Response to EBV
People with schizophrenia appear to have higher levels of antibodies against the Epstein-Barr virus (EBV), a ...
JANUARY 9, 2019
Load more